Skip to content

Surgical and Oncological Outcomes in Patients With Ulcerative Colitis-associated Rectal Cancer

Surgical and Oncological Outcomes in Patients With Ulcerative Colitis Associated Rectal Cancer: a Retrospective Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04659148
Acronym
UC-RectalK
Enrollment
40
Registered
2020-12-09
Start date
2020-10-01
Completion date
2021-04-01
Last updated
2020-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer, Ulcerative Colitis

Keywords

Ulcerative Colitis, Rectal Cancer

Brief summary

This is a retrospective observational study to investigate the short-term surgical outcomes, and long-term oncological outcomes of patients diagnosed with Ulcerative colitis and rectal cancer.

Detailed description

Inflammatory Bowel Disease (IBD) is a risk factor for the development of colorectal cancer (CRC). Despite improved targeted screening and timely prophylactic resection, up to 15% of all IBD-related mortality can be attributed to CRC. Previous reports suggest that IBD patients present with CRC at an earlier age and with more advanced disease than those with sporadic CRC. The literature is limited, however, with respect to colitis-associated rectal cancer (CARC), which has unique considerations such as surgical approach and the use of neoadjuvant therapy. Although total proctocolectomy is generally the procedure of choice for those with CARC, recent reports reported acceptable oncological outcomes after ileal pouch-anal anastomosis (IPAA) and ileorectal anastomosis (IRA). The impact of the type of surgical procedure on the oncologic outcome in patients with CARC is not well defined. The aim of this study is to investigate short-term surgical outcomes (postoperative complications at 30 days after surgery) and long-term oncological outcomes (disease-free survival) of CARC patients undergoing different surgical approaches.

Interventions

Total proctocolectomy: surgical removal of the colon, rectum, and anus

Sponsors

Istituto Clinico Humanitas
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with Ulcerative Colitis; * Patients diagnosed with rectal cancer (within 15 cm from the anal verge); * Patients who underwent surgery for rectal cancer between January 2004 and January 2020; * All type of surgery will be included; * Surgery in elective and emergency settings.

Exclusion criteria

* Patients aged\<18 years; * Patients with a diagnosis of undetermined colitis; * Insufficient follow-up data.

Design outcomes

Primary

MeasureTime frameDescription
Surgical outcome30 days after surgery30 days postoperative complications
Oncological outcome5 years after surgeryDisease-free survival

Countries

Italy, United Kingdom

Contacts

Primary ContactAnnalisa Maroli
annalisa.maroli@humanitas.it+390282247776

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026